206 related articles for article (PubMed ID: 29608068)
1. Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5.
Rossi Sebastiano M; Doak BC; Backlund M; Poongavanam V; Over B; Ermondi G; Caron G; Matsson P; Kihlberg J
J Med Chem; 2018 May; 61(9):4189-4202. PubMed ID: 29608068
[TBL] [Abstract][Full Text] [Related]
2. Solution Conformations Explain the Chameleonic Behaviour of Macrocyclic Drugs.
Danelius E; Poongavanam V; Peintner S; Wieske LHE; Erdélyi M; Kihlberg J
Chemistry; 2020 Apr; 26(23):5231-5244. PubMed ID: 32027758
[TBL] [Abstract][Full Text] [Related]
3. Managing Experimental 3D Structures in the Beyond-Rule-of-5 Chemical Space: The Case of Rifampicin.
Ermondi G; Lavore F; Vallaro M; Tiana G; Vasile F; Caron G
Chemistry; 2021 Jul; 27(40):10394-10404. PubMed ID: 34114271
[TBL] [Abstract][Full Text] [Related]
4. Going Viral: An Investigation into the Chameleonic Behaviour of Antiviral Compounds.
Wieske LHE; Atilaw Y; Poongavanam V; Erdélyi M; Kihlberg J
Chemistry; 2023 Feb; 29(8):e202202798. PubMed ID: 36286339
[TBL] [Abstract][Full Text] [Related]
5. Use of 3D properties to characterize beyond rule-of-5 property space for passive permeation.
Guimarães CR; Mathiowetz AM; Shalaeva M; Goetz G; Liras S
J Chem Inf Model; 2012 Apr; 52(4):882-90. PubMed ID: 22394163
[TBL] [Abstract][Full Text] [Related]
6. Cell permeability beyond the rule of 5.
Matsson P; Doak BC; Over B; Kihlberg J
Adv Drug Deliv Rev; 2016 Jun; 101():42-61. PubMed ID: 27067608
[TBL] [Abstract][Full Text] [Related]
7. Optimizing solubility and permeability of a biopharmaceutics classification system (BCS) class 4 antibiotic drug using lipophilic fragments disturbing the crystal lattice.
Tehler U; Fagerberg JH; Svensson R; Larhed M; Artursson P; Bergström CA
J Med Chem; 2013 Mar; 56(6):2690-4. PubMed ID: 23432334
[TBL] [Abstract][Full Text] [Related]
8. Design Principles for Balancing Lipophilicity and Permeability in beyond Rule of 5 Space.
Möbitz H
ChemMedChem; 2024 Mar; 19(5):e202300395. PubMed ID: 37986275
[TBL] [Abstract][Full Text] [Related]
9. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number.
Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ
Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957
[TBL] [Abstract][Full Text] [Related]
10. Opportunities and guidelines for discovery of orally absorbed drugs in beyond rule of 5 space.
Poongavanam V; Doak BC; Kihlberg J
Curr Opin Chem Biol; 2018 Jun; 44():23-29. PubMed ID: 29803972
[TBL] [Abstract][Full Text] [Related]
11. Absorption classification of oral drugs based on molecular surface properties.
Bergström CA; Strafford M; Lazorova L; Avdeef A; Luthman K; Artursson P
J Med Chem; 2003 Feb; 46(4):558-70. PubMed ID: 12570377
[TBL] [Abstract][Full Text] [Related]
12. Molecular inflation, attrition and the rule of five.
Leeson PD
Adv Drug Deliv Rev; 2016 Jun; 101():22-33. PubMed ID: 26836397
[TBL] [Abstract][Full Text] [Related]
13. Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs.
Whitty A; Zhong M; Viarengo L; Beglov D; Hall DR; Vajda S
Drug Discov Today; 2016 May; 21(5):712-7. PubMed ID: 26891978
[TBL] [Abstract][Full Text] [Related]
14. In silico prediction of the solubility advantage for amorphous drugs - Are there property-based rules for drug discovery and early pharmaceutical development?
Kuentz M; Imanidis G
Eur J Pharm Sci; 2013 Feb; 48(3):554-62. PubMed ID: 23262058
[TBL] [Abstract][Full Text] [Related]
15. Stereochemistry Balances Cell Permeability and Solubility in the Naturally Derived Phepropeptin Cyclic Peptides.
Schwochert J; Lao Y; Pye CR; Naylor MR; Desai PV; Gonzalez Valcarcel IC; Barrett JA; Sawada G; Blanco MJ; Lokey RS
ACS Med Chem Lett; 2016 Aug; 7(8):757-61. PubMed ID: 27563399
[TBL] [Abstract][Full Text] [Related]
16. Conformational Sampling Deciphers the Chameleonic Properties of a VHL-Based Degrader.
Ermondi G; Jimenez DG; Rossi Sebastiano M; Kihlberg J; Caron G
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678900
[TBL] [Abstract][Full Text] [Related]
17. Design Principles for Intestinal Permeability of Cyclic Peptides.
Mathiowetz AM
Methods Mol Biol; 2019; 2001():1-15. PubMed ID: 31134564
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Chameleonic Efficiency.
David L; Wenlock M; Barton P; Ritzén A
ChemMedChem; 2021 Sep; 16(17):2669-2685. PubMed ID: 34240561
[TBL] [Abstract][Full Text] [Related]
19. Controlling the Chameleonic Behavior and Membrane Permeability of Cyclosporine Derivatives via Backbone and Side Chain Modifications.
Lee D; Choi J; Yang MJ; Park CJ; Seo J
J Med Chem; 2023 Sep; 66(18):13189-13204. PubMed ID: 37718494
[TBL] [Abstract][Full Text] [Related]
20. Permeability prediction in the beyond-Rule-of 5 chemical space: Focus on cyclic hexapeptides.
Digiesi V; de la Oliva Roque V; Vallaro M; Caron G; Ermondi G
Eur J Pharm Biopharm; 2021 Aug; 165():259-270. PubMed ID: 34038796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]